• 1
    Aderem, A. and Underhill, D. M., Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 1999. 17: 593623.
  • 2
    Peiser, L., Mukhopadhyay, S. and Gordon, S., Scavenger receptors in innate immunity. Curr. Opin. Immunol. 2002. 14: 123128.
  • 3
    Stahl, P. D. and Ezekowitz, R. A., The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 1998. 10: 5055.
  • 4
    Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J., Andersson, L., Koehn, S., Rhee, J. S. et al., Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 2002. 277: 4998249988.
  • 5
    Tandon, N. N., Lipsky, R. H., Burgess, W. H. and Jamieson, G. A., Isolation and characterization of platelet glycoprotein IV (CD36). J. Biol. Chem. 1989. 264: 75707575.
  • 6
    Greenwalt, D. E., Lipsky, R. H., Ockenhouse, C. F., Ikeda, H., Tandon, N. N. and Jamieson, G. A., Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992. 80: 11051115.
  • 7
    Ottnad, E., Parthasarathy, S., Sambrano, G. R., Ramprasad, M. P., Quehenberger, O., Kondratenko, N., Green, S. and Steinberg, D., A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: Partial purification and role in recognition of oxidatively damaged cells. Proc. Natl. Acad. Sci. USA 1995. 92: 13911395.
  • 8
    Rigotti, A., Acton, S. L. and Krieger, M., The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 1995. 270: 1622116224.
  • 9
    Ren, Y., Silverstein, R. L., Allen, J. and Savill, J., CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 1995. 181: 18571862.
  • 10
    McGilvray, I. D., Serghides, L., Kapus, A., Rotstein, O. D. and Kain, K. C., Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: A role for CD36 in malarial clearance. Blood 2000. 96: 32313240.
  • 11
    Serghides, L. and Kain, K. C., Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. J. Immunol. 2001. 166: 67426748.
  • 12
    Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P. et al., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA 1997. 94: 43184323.
  • 13
    Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H. and Evans, R. M., Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998. 93: 229240.
  • 14
    Tontonoz, P., Hu, E. and Spiegelman, B. M., Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 1995. 5: 571576.
  • 15
    Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M. and Kliewer, S. A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 1995. 270: 1295312956.
  • 16
    Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C. and Lehmann, J. M., A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995. 83: 813819.
  • 17
    Yesner, L. M., Huh, H. Y., Pearce, S. F. and Silverstein, R. L., Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 1996. 16: 10191025.
  • 18
    Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L. et al., Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999. 400: 378382.
  • 19
    Zurawski, G. and de Vries, J. E., Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 1994. 15: 1926.
  • 20
    Mueller, T. D., Zhang, J. L., Sebald, W. and Duschl, A., Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim. Biophys. Acta 2002. 1592: 237250.
  • 21
    Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 2003. 3: 2335.
  • 22
    Rey, A., M'Rini, C., Sozzani, P., Lamboeuf, Y., Beraud, M., Caput, D., Ferrara, P. and Pipy, B., IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages. Biochim. Biophys. Acta 1998. 1393: 244252.
  • 23
    Coste, A., Dubourdeau, M., Linas, M. D., Cassaing, S., Lepert, J. C., Balard, P., Chalmeton, S. et al., PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. Immunity 2003. 19: 329339.
  • 24
    Leesnitzer, L. M., Parks, D. J., Bledsoe, R. K., Cobb, J. E., Collins, J. L., Consler, T. G., Davis, R. G. et al., Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 2002. 41: 66406650.
  • 25
    Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. and Glass, C. K., The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998. 391: 7982.
  • 26
    Berry, A., Chene, G., Benoit-Vical, F., Lepert, J. C., Bernad, J., Marchou, B., Seguela, J. P. et al., Ex vivo and in vitro impairment of CD36 expression and tumor necrosis factor-alpha production in human monocytes in response to Plasmodium falciparum-parasitized erythrocytes. J. Parasitol. 2005. 91: 316322.
  • 27
    Nozaki, S., Kashiwagi, H., Yamashita, S., Nakagawa, T., Kostner, B., Tomiyama, Y., Nakata, A. et al., Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 1995. 96: 18591865.
  • 28
    El Khoury, J. B., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M. Freeman, M. W. and Luster, A. D., CD36 mediates the innate host response to beta-amyloid. J. Exp. Med. 2003. 197: 16571666.
  • 29
    Silverstein, R. L., Asch, A. S. and Nachman, R. L., Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J. Clin. Invest. 1989. 84: 546552.
  • 30
    Griffin, E., Re, A., Hamel, N., Fu, C., Bush, H., McCaffrey, T. and Asch, A. S., A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. Nat. Med. 2001. 7: 840846.
  • 31
    Feng, J., Han, J., Pearce, S. F., Silverstein, R. L., Gotto, A. M., Jr., Hajjar, D. P. and Nicholson, A. C., Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J. Lipid Res. 2000. 41: 688696.
  • 32
    Nakagawa, T., Nozaki, S., Nishida, M., Yakub, J. M., Tomiyama, Y., Nakata, A., Matsumoto, K. et al., Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 1998. 18: 13501357.
  • 33
    Wills-Karp, M., IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 2001. 107: 918.
  • 34
    Finkelman, F. D., Wynn, T. A., Donaldson, D. D. and Urban, J. F., The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Curr. Opin. Immunol. 1999. 11: 420426.
  • 35
    Tontonoz, P., Nagy, L., Alvarez, J. G., Thomazy, V. A. and Evans, R. M., PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998. 93: 241252.
  • 36
    Gosset, P., Charbonnier, A. S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A. B. and Trottein, F., Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur. J. Immunol. 2001. 31: 28572865.
  • 37
    Jeannin, P., Bottazzi, B., Sironi, M., Doni, A., Rusnati, M., Presta, M., Maina, V. et al., Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005. 22: 551560.
  • 38
    Triantafilou, M., Gamper, F. G., Haston, R. M., Mouratis, M. A., Morath, S., Hartung, T. and Triantafilou, K., Membrane sorting of Toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 2006. 281: 3100231011.
  • 39
    Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S. et al., CD36 is a sensor of diacylglycerides. Nature 2005. 433: 523527.
  • 40
    Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. and Mathison, J. C., CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990. 249: 14311433.
  • 41
    Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y. and Henson, P. M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998. 101: 890898.
  • 42
    Krutzik, S. R., Ochoa, M. T., Sieling, P. A., Uematsu, S., Ng, Y. W., Legaspi, A., Liu, P. T. et al., Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 2003. 9: 525532.
  • 43
    Ishii, T., Itoh, K., Ruiz, E., Leake, D. S., Unoki, H., Yamamoto, M. and Mann, G. E., Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: Activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 2004. 94: 609616.
  • 44
    Ikeda, Y., Sugawara, A., Taniyama, Y., Uruno, A., Igarashi, K., Arima, S., Ito, S. and Takeuchi, K., Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with Nrf2. J. Biol. Chem. 2000. 275: 3314233150.
  • 45
    Murata, T., Noguchi, P. D. and Puri, R. K., IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: Similarities between IL-4 and IL-13 signaling. J. Immunol. 1996. 156: 29722978.
  • 46
    Zhang, L. and Chawla, A., Role of PPARgamma in macrophage biology and atherosclerosis. Trends Endocrinol. Metab. 2004. 15: 500505.
  • 47
    Hart, P. H., Bonder, C. S., Balogh, J., Dickensheets, H. L., Donnelly, R. P. and Finlay-Jones, J. J., Differential responses of human monocytes and macrophages to IL-4 and IL-13. J. Leukoc. Biol. 1999. 66: 575578.
  • 48
    Yang, M. S., Ji, K. A., Jeon, S. B., Jin, B. K., Kim, S. U., Jou, I. and Joe, E., Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: Implications for death of activated microglia. J. Immunol. 2006. 177: 13231329.
  • 49
    Imai, T., Takakuwa, R., Marchand, S., Dentz, E., Bornert, J., Messaddeq, N., Wendling, O. et al., Peroxisome proliferator -- activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl. Acad. Sci. USA 2004. 101: 45434547.
  • 50
    Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. and Forster, I., Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999. 8: 265277.
  • 51
    Trager, W. and Jensen, J. B., Human malaria parasites in continuous culture. Science 1976. 193: 673675.
  • 52
    Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M. and Uchida, K., 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J. Biol. Chem. 2002. 277: 1045910466.